We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Using the unusual color properties of gold at the nanoscale, scientists at Northwestern University have developed a "litmus test" for DNA and small molecule binding that eventually could be used by pharmaceutical companies to rapidly identify promising candidates for new anti-cancer drugs.
Optimata Ltd., a science-based, interdisciplinary company, dedicated to the development of predictive bio simulation technologies, announced the completion of the first phase of a pilot collaboration project with Eli Lilly & Co.
Israel-based pharmaceutical company NasVax has entered into an agreement with hepatitis expert Daniel Shouval, director of the Liver Unit Division of Medicine at Hadassah University Hospital in Jerusalem.
California-based biotechnology firm SGX Pharmaceuticals has signed an agreement with Swiss drugmaker Novartis to develop and market new BCR-ABL inhibitors, which are used to treat patients with chronic myelogenous leukemia (CML).
Iceland-based generic drugmaker Actavis will acquire Romanian pharmaceutical company Sindan, which specializes in the manufacturing and distribution of oncology products, for $177 million in cash.
The Indian government has announced plans for a new network of public health institutes that will aim to improve the country's lagging healthcare system
Jacobs Engineering Group Inc. announced today that a subsidiary company has been awarded a contract to provide engineering, procurement, construction, and commissioning services at Pfizer Limited's site at Sandwich in Kent, England.
A contraceptive pill that may reduce the risk of breast cancer and heart disease and eliminate periods could be available within the next five to 10 years.
Immunicon Corporation announced today an extension of its Research and Development Agreement with Pfizer, Inc., under which the Company collaborates with Pfizer to develop new reagents designed to detect certain undisclosed antigens on circulating tumor cells (CTCs).